GlassScriptPhysician profile
Erin M Ferguson
NPI 1043734452
$892.43
in general payments reported to CMS, 2019-2025
19 companies · $227 in 2025
The $227 reported for 2025 was more than what 78% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.72 · 2022: $125 · 2023: $173 · 2024: $291 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $100.32 | 2023-2024 | |
| Cranial Technologies, INC | $87.33 | 2021-2024 | Doc Band |
| Sanofi Pasteur INC. | $80.71 | 2022-2024 | |
| Cumberland Pharmaceuticals, INC. | $79.38 | 2025 | Caldolor |
| Merck Sharp & Dohme LLC | $75.04 | 2022-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Glaxosmithkline, LLC. | $70.15 | 2022-2025 | Bexsero, Shingrix |
| Tris Pharma INC | $69.67 | 2024-2025 | Dyanavel Xr, Onyda Xr |
| Acadia Pharmaceuticals INC | $54.02 | 2024-2025 | Daybue |
| Corium, LLC | $41.16 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $38.67 | 2021-2024 | |
| Medtronic, INC. | $34.94 | 2025 | Unid_pass |
| Phadia US INC. | $30.78 | 2024 | Immunocap |
| Verrica Pharmaceuticals INC. | $23.23 | 2024 | Ycanth |
| Takeda Pharmaceuticals U.S.A., INC. | $22.12 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $19.58 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $17.52 | 2025 | Neffy |
| Astrazeneca Pharmaceuticals LP | $17.38 | 2024 | Flumist Quadrivalent |
| Supernus Pharmaceuticals, INC. | $17.35 | 2025 | Qelbree |
| Ferring Pharmaceuticals INC. | $13.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.